People who have advanced non-small cell lung cancer may help slow down the progression of the disease by taking crizotinib twice daily. This prescription medication works by blocking the activity of certain proteins in the body that the cancer cells need to grow. Side effects may include vomiting, constipation, and vision problems.
What Is Crizotinib?
Crizotinib (Xalkori®) is a prescription medication approved to treat a certain type of lung cancer known as non-small cell lung cancer. It is licensed for use in people who have a specific gene called the abnormal anaplastic lymphoma kinase (ALK) gene. An abnormal ALK gene is responsible for cancer growth in a small percentage of people with non-small cell lung cancer.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Xalkori [package insert]. New York, NY: Pfizer, Inc.;2013 October.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 20, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click